Demographic characteristics, torture experiences, and posttraumatic stress disorder symptoms among asylum seekers and refugees persecuted for same‐sex behaviors. Issue 4 (22nd March 2022)

• Record Type: Journal Article
• Authors: Bird, Christine; Bowers, Gray; Piwowarczyk, Lin; Ng, Lauren C.
• Is Part Of: Journal of traumatic stress. Volume 35:Issue 4(2022)
• Page Start: 1167
• Page End: 1176
• Publication Date: 2022-03-22
• Subjects: Post-traumatic stress disorder -- Periodicals; 616.8521
• DOI: 10.1002/jts.22827
• Languages: English
• ISSNs: 0894-9867

Abstract

Abstract: Increasingly, lesbian, gay, and bisexual (LGB) individuals are fleeing the 67 countries that criminalize consensual same‐sex intimate relationships, seeking asylum in countries such as the United States. Minority stress theory posits that compared with non‐LGB refugees and asylum seekers (RAS), LGB RAS are likely to face persecution, rejection, and discrimination and have a higher risk of experiencing posttraumatic stress disorder (PTSD) symptoms. This study assessed differences in sociodemographic characteristics, persecution experiences, and mental health outcomes among 959 RAS persecuted for same‐sex behavior (pLGB RAS) who presented for care and social services at the Boston Center for Refugee Health and Human Rights. Data were derived from intake interviews with RAS clients that elicited torture experiences and assessed PTSD symptoms using the Short Screening Scale for PTSD. Over 11% of the total sample were pLGB RAS. Compared with non–pLGB RAS, pLGB RAS reported higher PTSD symptom levels, β = .08, p = .031; more difficulty loving others, d = 0.13, p < .001; and feeling more isolated, d = 0.10, p = .005. pLGB RAS reported more persecution, d = 0.31, p = .002; physical assaults, d = 0.22, p = .029; and psychological assaults, d = 0.20, p = .047; and were more likely to be asylum seekers, d = 0.11, p = .001, and have experienced persecution in Uganda, d = 0.39, p < .001, and other countries that criminalize same‐sex acts, d = 0.26, p < .001. More research is needed to understand clinical outcomes and implications of treatment for this population.